In contrast, high expression of ANKRD29 inhibits the proliferation and migration of NSCLC cells, improves anti-tumor immunity by enhancing T cell cytotoxicity (Zhao et al., 2022a), and may counteract the pro-tumor effects of the NF-κB/MAPK axis. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.